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We investigated whether urinary (U) 8-hydroxy-2′-deoxyguanosine (8-OHdG), an oxidative DNA damage marker, was related to inflammatory activity 
in cardiac sarcoidosis(CS). 
Methods: U-8-OHdG levels were measured in 31 CS patients, classified as active (n = 17) or non-active (n = 14) based on 18F-FDG-PET/CT. In 
active CS patients, U-8-OHdG levels were re-examined and compared with 18F-FDG-PET/CT results at 6 months after corticosteroid treatment to 
assess therapeutic response. 
results: Immunohistochemical examination of left ventricle (LV) autopsy samples from CS patients revealed positive 8-OHdG staining in 
cardiomyocyte nuclei from LV sections showing 18F-FDG accumulation on PET/CT, while serum 8-OHdG levels were significantly higher in the 
coronary sinus than in the aortic root only in active CS patients. U-8-OHdG levels in CS patients were higher than those in controls, and significantly 
higher in active CS patients than in non-active CS patients. U-8-OHdG was a powerful predictor of active CS in ROC curve analysis (AUC, 0.98; 
optimal cutoff value, 13.1 ng/mg creatinine; sensitivity, 88.2%; specificity, 92.9%). U-8-OHdG level in patients with active CS was significantly 
decreased 6 months after corticosteroid treatment, in proportion with a decrease in the focal pathological tracer uptake in heart. 
conclusions: U-8-OHdG is a potentially clinically useful biomarker for evaluating inflammatory activity and monitoring the effectiveness of 
corticosteroid therapy in CS patients.
 
